|
Index of reports
> Cases resulting in death (19)
> Cases with Dyspnoea (3)
Below is the selection of adverse event reports related to Requip (Ropinirole) that includes cases resulting in death where reactions include dyspnoea.
Adverse event in 73 year old male receiving Requip (Ropinirole)
Reported by a consumer/non-health professional from United States on 2007-06-15
Patient: 73 year old male
Adverse reactions / side effects: Dyspnoea, Dyspnoea Exertional, Interstitial Lung Disease
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Suspect drug(s):
Requip (Ropinirole)
Other drugs received by patient: Heart Medication
Adverse event in 73 year old male receiving Requip (Ropinirole)
Reported by a consumer/non-health professional from United States on 2007-06-14
Patient: 73 year old male
Adverse reactions / side effects: Dyspnoea, Dyspnoea Exertional, Interstitial Lung Disease
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Suspect drug(s):
Requip (Ropinirole)
Other drugs received by patient: Heart Medication
Adverse event in 69 year old male receiving Requip (Ropinirole)
Reported by a consumer/non-health professional from France on 2007-03-26
Patient: 69 year old male
Adverse reactions / side effects: Dyspnoea, Anaemia, Neutropenia, Purpura, Melaena, Thrombocytopenia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Requip
Dosage: 1tab three times per day
Administration route: Oral
Indication: Parkinson's Disease
Cordarone
Dosage: 1tab per day
Administration route: Oral
Start date: 2007-02-01
End date: 2007-02-22
Lasix
Dosage: 20mg per day
Administration route: Oral
Start date: 2006-12-15
End date: 2007-02-22
Modopar
Administration route: Oral
Indication: Parkinson's Disease
Sinemet
Dosage: 50mg twice per day
Administration route: Oral
Indication: Parkinson's Disease
Ketoprofen
Administration route: Oral
Start date: 2007-02-10
End date: 2007-02-22
Atacand
Dosage: 8mg per day
Administration route: Oral
Start date: 2006-12-15
End date: 2007-02-22
Stalevo 100
Dosage: 1tab three times per day
Administration route: Oral
Indication: Parkinson's Disease
Other drugs received by patient: Burinex
|
